Effects of rosuvastatin on expression of angiotensin-converting enzyme 2 after vascular balloon injury in rats

Journal of Geriatric Cardiology

Volumn 10, Issue 2, 2013, Pages 151-158

  Li, Yong Hong ^a   Wang, Qi Xin ^a   Zhou, Jing Wei ^a   Chu, Xian Ming ^a   Man, Yu Lin ^a   Liu, Ping ^a   Ren, Bei Bei ^a   Sun, Ting Ru ^a   An, Yi ^a  

^a QINGDAO UNIVERSITY   (China)

Author keywords

Angiotensin converting enzyme 2; Balloon injury; Extracellular signal regulated kinase; Rosuvastatin

Indexed keywords

ANGIOTENSIN CONVERTING ENZYME 2; ANGIOTENSIN[1-7]; CYCLINE; MITOGEN ACTIVATED PROTEIN KINASE 1; ROSUVASTATIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY INTIMA PROLIFERATION; ARTICLE; BALLOON CATHETER; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; PROTEIN EXPRESSION; RADIOIMMUNOASSAY; RADIOIMMUNOLOGY; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE; WESTERN BLOTTING;

EID: 84883271023     PISSN: 16715411     EISSN: None     Source Type: Journal    
DOI: 10.3969/j.issn.1671-5411.2013.02.009     Document Type: Article

References (12)

1. Curcio A TD, Indolfi C. Mechanisms of smooth muscle cell poliferation and endothelial regeneration after vascular injury and stenting. Circ J 2011; 75: 1287-1296.
2. Rabelo LA, Alenina N, Bader M. ACE2-angiotensin-(1-7)-Mas axis and oxidative stress in cardiovascular disease. Hypertens Res 2011; 34: 154-160.
3. Preusch MR, Vanakaris A, Bea F, et al. Rosuvastatin reduces neointima formation in a rat model of balloon injury. Eur J Med Res 2010; 15: 461-467.
4. Briones AM, Rodríguez-Criado N, Hernanz R, et al. Atorvastatin prevents angiotensin II-induced vascular remodeling and oxidative stress. Hypertension. 2009; 54: 142-149.
5. Marx SO, Totary-Jain H, Marks AR. Vascular smooth muscle cell proliferation in restenosis. Circ Cardiovasc Interv 2011;4: 104-111.
6. Santos RA, Ferreira AJ, Verano-Braga T, et al. Angiotensin-converting enzyme 2, angiotensin-(1-7) and Mas: new players of the renin-angiotensin system. J Endocrinol 2013; 216: R1-R17.
7. Shi L, Mao C, Xu Z, et al. Angiotensin-converting enzymes and drug discovery in cardiovascular diseases. Drug Discov Today 2010, 15: 332-341.
8. Zhang F, Hu Y, Xu Q, et al. Different effects of angiotensin II and angiotensin-(1-7) on vascular smooth muscle cell proliferation and migration. PLoS One 2010; 5: e12323.
9. Xu W, Guo T, Zhang Y, et al. The inhibitory effect of dexamethasone on platelet-derived growth factor-induced vascular smooth muscle cell migration through up-regulating PGC-1α expression. Exp Cell Res 2011; 317: 1083-1892.
10. Wu JR, Liou SF, Lin SW, et al. Lercanidipine inhibits vascular smooth muscle cell proliferation and neointimal formation via reducing intracellular reactive oxygen species and inactivating Ras-ERK1/2 signaling. Pharmacol Res 2009; 59: 48-56.
11. Yoo AR, Koh SH, Cho GW, et al. Inhibitory effects of cilostazol on proliferation of vascular smooth muscle cells (VSMCs) through suppression of the ERK1/2 pathway. J Atheroscler Thromb 2010; 17: 1009-1018.
12. Qiang B, Toma J, Fujii H, et al. Statin therapy prevents expansive remodeling in venous bypass grafts. Atherosclerosis 2012; 223: 106-113.